Optimizing Mineralocorticoid Receptor Antagonist Therapy in Heart Failure Through Integrated Care Strategies
{{output}}
Background: Hyperkalemia is a critical barrier to mineralocorticoid receptor antagonist (MRA) optimization in heart failure (HF) patients with reduced ejection fraction (HFrEF). ... ...
